ASTEC LifeSciences Limited has announced comprehensive changes to its board structure following a meeting held on April 13, 2026, marking a significant transition in the company's leadership framework under Regulation 30 of SEBI Listing Obligations.

Leadership Transition at the Top

The board noted the retirement of Mr. Nadir Godrej from his position as Chairperson and Director, effective from the close of business hours on April 13, 2026. Mr. Godrej, who will turn 75 in August 2026, expressed his intention to step down in his retirement letter, stating his confidence in the leadership team's ability to create sustainable long-term value for stakeholders.

New Chairman Appointment

The board has appointed Mr. Vishal Sharma as Additional Director (Non-Executive, Non-Independent) and Chairperson, effective from the close of business hours on April 13, 2026, subject to shareholder approval. Mr. Sharma brings extensive experience as Executive Director & Chief Executive Officer (Chemicals) of Godrej Industries Limited, the ultimate holding company.

Managing Director Transition

Mr. Burjis N. Godrej has resigned from his position as Managing Director with immediate effect, citing his intention to have deeper involvement in Godrej Agrovet Limited, the parent company. He will continue serving on the board as a Non-Executive Director, subject to shareholder approval.

Additional Board Appointments

The board has approved two additional appointments to strengthen its composition:

Mr. Mathew Eipe has been appointed as Additional Non-Executive Independent Director for a term from April 13, 2026, to June 6, 2027, subject to shareholder approval. He serves as Independent Director of Godrej Industries Limited and brings extensive experience from his tenure with the Godrej Group, including leadership of the Chemicals business until his retirement in 2013.

Mr. Arijit Mukherjee has been appointed as Additional Executive Director & Chief Operating Officer for a three-year term from April 13, 2026, to April 12, 2029, subject to shareholder approval. Currently serving as Chief Operating Officer, he brings over 20 years of experience in the Agri Inputs business and has been associated with Godrej Agrovet Limited since 2005.

Board Composition and Regulatory Compliance

Following these changes, the board will comprise 10 directors, maintaining balanced governance with 5 independent directors (50%) and 5 non-independent directors (50%). All appointments are subject to shareholder approval and comply with applicable provisions of the Companies Act, 2013, and SEBI Listing Regulations.

The company has confirmed that all newly appointed directors are eligible under relevant regulations and are not debarred from holding directorship positions by SEBI or any other authority. The board meeting commenced at 4:00 p.m. and concluded at 4:14 p.m. on April 13, 2026.

Astec LifeSciences Limited has submitted its quarterly compliance certificate to stock exchanges, fulfilling regulatory requirements under SEBI's depositories framework. The certificate pertains to the quarter ended March 31, 2026, and was filed with both BSE and National Stock Exchange of India Limited on April 10, 2026.

Regulatory Compliance Filing

The compliance certificate was filed pursuant to Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018. Company Secretary and Compliance Officer Tejashree Pradhan signed the submission letter, which was digitally authenticated on April 10, 2026.

Certificate Contents and Confirmations

Bigshare Services Private Limited, serving as the company's Registrar and Share Transfer Agent, issued the compliance certificate dated April 3, 2026. The certificate confirms specific operational details regarding dematerialization activities during the quarter.

According to the certificate signed by Akash Shamal, Authorized Signatory of Bigshare Services:

• No securities were received from depository participants for dematerialization up to March 31, 2026
• No certificates required mutilation or cancellation due to absence of dematerialization requests
• No substitution of depositories' names in the register of members was necessary within the 15-day regulatory timeframe

Stock Exchange Submissions

The compliance certificate was simultaneously submitted to both major Indian stock exchanges where Astec LifeSciences shares are listed.

Company Certifications

Astec LifeSciences maintains multiple international quality and environmental certifications, including ISO 9001:2015 for quality management, ISO 14001:2015 for environmental management, and OHSAS 45001:2018 for occupational health and safety standards. The company also participates in the Responsible Care initiative, demonstrating its commitment to sustainability practices.

The quarterly compliance filing represents part of the company's ongoing regulatory obligations as a publicly listed entity, ensuring transparency in share transfer and dematerialization processes for investor protection.